SCHEMBL17656288

SCHEMBL17656288

O=C(CBr)C12CCC3(c4cccc(Br)c4)CC13CC2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
GAA P10253 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HCAR3 P49019 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
CTSD P07339 1/20 0.32
BACE1 P56817 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PTGFR P43088 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
MAPT P10636 1/20 0.31
LMNA P02545 1/20 0.31
PLA2G1B P04054 1/20 0.31
HTT P42858 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ATG4B Q9Y4P1 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19339694 1.00 ALDH1A1 (0.35) ALDH1A1GAASMN1; SMN2NPSR1HCAR3
SCHEMBL16001516 0.76 ALDH1A1 (0.39) ALDH1A1GAASMN1; SMN2NPSR1HCAR3
SCHEMBL205306 0.71 ALDH1A1 (0.39) ALDH1A1GAASMN1; SMN2NPSR1HCAR3
SCHEMBL19339371 0.67 HDAC1 (0.33) ALDH1A1GAASMN1; SMN2PTGFRMAPT
SCHEMBL671822 0.62 AKR1C1 (0.53) ALDH1A1GAASMN1; SMN2NPSR1HCAR3
SCHEMBL15513651 0.62 ALDH1A1 (0.47) ALDH1A1GAASMN1; SMN2NPSR1HCAR3
SCHEMBL21200393 0.62 ALDH1A1 (0.39) ALDH1A1GAASMN1; SMN2NPSR1HCAR3
SCHEMBL29575175 0.62 ALDH1A1 (0.39) ALDH1A1GAASMN1; SMN2NPSR1HCAR3
SCHEMBL30016494 0.61 PARP1 (0.47) ALDH1A1GAASMN1; SMN2NPSR1HCAR3
SCHEMBL3926671 0.61 PARP1 (0.47) ALDH1A1GAASMN1; SMN2NPSR1HCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3309157-A1 ANTIVIRAL COMPOUNDS Gilead Pharmasset LLC (US) 2018-04-18 EP disclosed
EP-3002281-B1 ANTIVIRAL COMPOUNDS GILEAD PHARMASSET LLC (US) 2017-09-13 EP disclosed
EP-3002281-A1 ANTIVIRAL COMPOUNDS Gilead Pharmasset LLC (US) 2016-04-06 EP disclosed